David W. Hecht

2.0k citations

41 papers · 1.6k indexed · h-index 22

Impact in

Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing
Infectious Diseases top 2%
- Clostridium difficile and Clostridium perfringens research
- Viral gastroenteritis research and epidemiology
- Antimicrobial Resistance in Staphylococcus

Papers in

Clinical Biochemistry 19
- Bacterial Identification and Susceptibility Testing 19
Molecular Medicine 6
- Antibiotic Resistance in Bacteria 6

Co-authors: Dale N. Gerding Stuart Johnson James R. Osmolski Minerva Galang Susan P. Sambol Gayatri Vedantam Jennifer R. O’Connor Hannah M. Wexler
Journals: Clinical Infectious Diseases (9 papers)Antimicrobial Agents and Chemotherapy (6 papers)Journal of Bacteriology (4 papers)Molecular Microbiology (2 papers)The American Journal of Surgery (2 papers)
Partner nations: United States United Kingdom Sweden

In The Last Decade

David W. Hecht

41 papers receiving 1.5k citations

Peers

Countries citing papers authored by David W. Hecht

Since Specialization

Citations

This map shows the geographic impact of David W. Hecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Hecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Hecht more than expected).

Fields of papers citing papers by David W. Hecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Hecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Hecht. The network helps show where David W. Hecht may publish in the future.

Co-authors

The 25 scholars most cited alongside David W. Hecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David W. Hecht Line = papers co-authored together David W. Hecht links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Changes in the antibiotic susceptibility of anaerobic bacteria from 2007–2009 to 2010–2012 based on the CLSI methodology Anaerobe ·Christine J. Hastey, Niago Silva Rigo, Audrey N. Schuetz, Karen Anderson, Diane M. Citron, Rupert Wontner, Meredith Hackel, David W. Hecht, N V Jacobus, Stephen G. Jenkins, Maria Karlsson, C C Knapp, Laura Koeth, Hannah M. Wexler, AlineChiancaDantas	2016	39
2	Emergence and evolution of an international cluster of MDRBacteroides fragilisisolates Journal of Antimicrobial Chemotherapy ·József Sóki, Maria Hedberg, Sheila Patrick, Balázs Bálint, Róbert Herczeg, István Nagy, David W. Hecht, Elisabeth Nagy, Edit Urbán	2016	45
3	Diversity of Clostridium perfringens isolates from various sources and prevalence of conjugative plasmids Anaerobe ·Miseon Park, Joanna Deck, Steven L. Foley, Rajesh Nayak, J. Glenn Songer, Wang Feng-hong, Saeed Khan, Alejandro P. Rooney, David W. Hecht, Fatemeh Rafii	2015	17
4	Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007) Clinical Infectious Diseases ·David R. Snydman, N V Jacobus, Yenni Agustin, Yoav Golan, David W. Hecht, Ellie J. C. Goldstein, Lizzie J. Harrell, Stephen G. Jenkins, Duane W. Newton, Carl L. Pierson, John D. Rihs, Victor L. Yu, Richard A. Venezia, Sydney M. Finegold, Jon E. Rosenblatt, Sherwood L. Gorbach	2010	110
5	Phenotypic and genotypic characterization of tetracycline and minocycline resistance in Clostridium perfringens Archives of Microbiology ·Miseon Park, Alejandro P. Rooney, David W. Hecht, Jihong Li, Bruce A. McClane, Rajesh Nayak, G. Sbarigia, Fatemeh Rafii	2010	26
6	The Novel Antibacterial Drug XF-70 is a Potent Inhibitor of Staphylococcus aureus Infection of the Burn Wound Journal of Burn Care & Research ·ME Jun Taniguchi BE, Jong-Wok Jung, Andrea Szilágyi, Richard L. Gamelli, David W. Hecht, Richard H. Kennedy, W. Rhys‐Williams, William G. Love, Ravi Shankar	2010	3
7	Association of EnterotoxigenicBacteroides fragilisInfection with Inflammatory Diarrhea Clinical Infectious Diseases ·Cynthia L. Sears, Salequl Islam, Amit Saha, T. Maina-Nock, Nur Alam, Shah M. Faruque, Mohammed Abdus Salam, Jai W. Shin, David W. Hecht, Andrej Weintraub, R. Bradley Sack, Firdausi Qadri	2008	115
8	Characterization of BctA, a mating apparatus protein required for transfer of the Bacteroides fragilis conjugal element BTF-37 Research in Microbiology ·David W. Hecht, Melissa Patack, Adea Oktavia, Gayatri Vedantam	2007	5
9	Interaction of Bacteroides fragilis pLV22a relaxase and transfer DNA with Escherichia coli RP4‐TraG coupling protein Molecular Microbiology ·Johnson Thomas, David W. Hecht	2007	12
10	Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole Diagnostic Microbiology and Infectious Disease ·Sandra Deitermann, George L. Drusano, David W. Hecht, John C. Rotschafer, Larry H. Danziger, Keith A. Rodvold	2006	31
11	Bacteroides fragilis mobilizable transposon Tn5520 requires a 71 base pair origin of transfer sequence and a single mobilization protein for relaxosome formation during conjugation Molecular Microbiology ·M Becker drs., Adea Oktavia, David W. Hecht	2005	14
12	Anaerobes: Antibiotic resistance, clinical significance, and the role of susceptibility testing Anaerobe ·David W. Hecht	2005	95
13	Antibiotics and anaerobes of gut origin Current Opinion in Microbiology ·M Becker drs., David W. Hecht	2003	36
14	Evolution of Anaerobe Susceptibility Testing in the United States Clinical Infectious Diseases ·David W. Hecht	2002	12
15	Antibiotic Resistance Among Anaerobes: What Does it Mean? Anaerobe ·David W. Hecht, Gayatri Vedantam, James R. Osmolski	1999	17
16	Do topical antibiotics provide improved prophylaxis against bacterial growth in the presence of polypropylene mesh? The American Journal of Surgery ·Andrew S. Luk, Philippe Falbet, Philip B. Dobrin, David W. Hecht	1996	22
17	Analysis of Trends in Antimicrobial Resistance Patterns Among Clinical Isolates of Bacteroides fragilis Group Species from 1990 to 1994 Clinical Infectious Diseases ·David R. Snydman, L. A. McDermott, G J Cuchural, David W. Hecht, Paul B. Iannini, Lizzie J. Harrell, Stephen G. Jenkins, J. Paul O'Keefe, Carl L. Pierson, John D. Rihs, Victor L. Yu, Sydney M. Finegold, Sherwood L. Gorbach	1996	45
18	In Vitro Susceptibility of Anaerobes to Quinolones in the United States Clinical Infectious Diseases ·David W. Hecht, Hannah M. Wexler	1996	33
19	Susceptibility Results for the Bacteroides fragilis Group: Comparison of the Broth Microdilution and Agar Dilution Methods Clinical Infectious Diseases ·David W. Hecht, Lakhdar Touhami, James R. Osmolski	1995	5
20	Variation in the Susceptibility of Bacteroides fragilis Group Isolates from Six Chicago Hospitals Clinical Infectious Diseases ·David W. Hecht, James R. Osmolski, J. Paul O'Keefe	1993	31

About David W. Hecht

David W. Hecht is a scholar working on Clinical Biochemistry, Molecular Medicine, Endocrinology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (19 papers), Clostridium difficile and Clostridium perfringens research (15 papers), Bacterial Genetics and Biotechnology (7 papers), Streptococcal Infections and Treatments (7 papers), Antibiotic Resistance in Bacteria (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Diphtheria, Corynebacterium, and Tetanus (4 papers). The work is most often cited by research in Clinical Biochemistry (510 citations), Infectious Diseases (878 citations), Molecular Medicine (230 citations), Applied Microbiology and Biotechnology (84 citations) and Endocrinology (115 citations). David W. Hecht has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Dale N. Gerding, Stuart Johnson, James R. Osmolski, Minerva Galang, Susan P. Sambol, Gayatri Vedantam, Jennifer R. O’Connor, Hannah M. Wexler, Toral Patel and Christopher Schriever. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Bacteriology, Molecular Microbiology and The American Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact